AllSight
Companies · IDXX · In Vitro & In Vivo Diagnostic Substances

IDEXX LABORATORIES INC /DE (IDXX)

IDEXX LABORATORIES INC /DE (IDXX) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

IDEXX LABORATORIES INC /DE (IDXX) stock — financials & valuation

Key numbers for IDEXX LABORATORIES INC /DE (IDXX): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 61/100 — a percentile rank of IDEXX LABORATORIES INC /DE’s fundamentals against Manufacturing peers, weakest on valuation. A quality ranking, not a price prediction.

Market cap$41.1B
P / E36.1×
P / S9.0×
EV / EBITDA26.0×
Gross margin62.4%
Operating margin32.0%
Net margin25.0%
Return on equity70.7%
ROIC48.9%
Revenue growth12.8%
Debt / equity0.6×
Dividend yield0.0%

Is IDEXX LABORATORIES INC /DE overvalued? P/E looks undervalued vs its 5-year range; P/S looks undervalued vs its 5-year range; EV/EBITDA looks undervalued vs its 5-year range; P/B looks undervalued vs its 5-year range.

Independent of the events above — derived from IDEXX LABORATORIES INC /DE’s own financial statements and shown as context, never as advice.

Aug 4, 2026Beat
EPS beat and full-year outlook rose, despite softer instrument revenue
Related companies in In Vitro & In Vivo Diagnostic Substances
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact